Receptor distribution determines how VIP work in unique condition versions. In colitis research, VPAC1 expression raises in inflamed intestinal mucosa, building exogenous VIP more effective through active inflammation than in wholesome tissue. In contrast, VPAC2-mediated effects on pancreatic insulin secretion stay steady regardless of inflammatory